Back to Market Feed

Product Information

DISOPYRAMIDE 150 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.5006 per EA under NDC 00093312901. Its NADAC has been published 644 times since Nov 28, 2013.

FDA first approved this application on Feb 22, 1985. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DISOPYRAMIDE 150 MG CAPSULE

Disopyramide Phosphate
$1.5006per EA

Strength

150 mg/1

NDC

00093312901

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DISOPYRAMIDE PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA070102

FDA Approved

2/22/1985

TE Code

AB

On Market Since

9/30/1990

Pharmacological Classes

Antiarrhythmic

Price Statistics

The NADAC for DISOPYRAMIDE 150 MG CAPSULE has been published 644 times since Nov 28, 2013, and over the history we have for it it has risen 396.5%. The table below summarizes its recorded NADAC range and movement.

Current price$1.5006 per EA
All-time high$1.8360 (May 15, 2019)
All-time low$0.2919 (Sep 17, 2014)
52-week high$1.7091
52-week low$1.4907
Median price$1.4702
Average price$1.3407
Largest weekly change+203.5% (Apr 20, 2016)
Weeks tracked644
Tracking sinceNov 28, 2013

Price History

1W

-2.3%

1M

-2.3%

3M

-7.3%

6M

-12.2%

1Y

-10.0%

3Y

-4.0%

5Y

-1.6%

All

+396.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Disopyramide Phosphate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

BURN RELIEF 0.5% SPRAY
Generic
70000062401•Cardinal Health
$0.0276
per GM
BURN RELIEF 0.5% SPRAY
Generic
46122055528•AmerisourceBergen
$0.0280
per GM
GNP LIDOCAINE HCL 4% CREAM
Generic
46122061410•AmerisourceBergen
$0.0517
per GM
LIDOCAINE HCL 4% CREAM
Generic
70000009801•Cardinal Health
$0.0517
per GM
LIDOCAINE HCL 1% VIAL
Generic
00409427602•Hospira Inc.
$0.0542
per ML
LIDOCAINE HCL 2% VIAL
Generic
00409427702•Hospira Inc.
$0.0569
per ML
LIDOCAINE HCL 1% 300 MG/30 ML
Generic
55150016300•Eugia US LLC
$0.0674
per ML
LIDOCAINE HCL 1% 300 MG/30 ML
Generic
55150016330•Eugia US LLC
$0.0674
per ML
LIDOCAINE HCL 1% VIAL
Generic
00143957710•Hikma Pharmaceuticals USA Inc.
$0.0694
per ML
LIDOCAINE HCL 1% VIAL
Generic
00409427601•Hospira Inc.
$0.0694
per ML

Frequently asked questions

What is the NADAC price of DISOPYRAMIDE 150 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for DISOPYRAMIDE 150 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $1.5006 per EA (NDC 00093312901), effective Aug 19, 2026.

How has the price of DISOPYRAMIDE 150 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for DISOPYRAMIDE 150 MG CAPSULE has risen 396.5%. It has been tracked across 644 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for DISOPYRAMIDE 150 MG CAPSULE?

Since Nov 28, 2013, the NADAC for DISOPYRAMIDE 150 MG CAPSULE has ranged from a low of $0.2919 (Sep 17, 2014) to a high of $1.8360 (May 15, 2019), with a median of $1.4702 per EA.

Are there cheaper alternatives to DISOPYRAMIDE 150 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of DISOPYRAMIDE 150 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DISOPYRAMIDE 150 MG CAPSULE?

DISOPYRAMIDE 150 MG CAPSULE (NDC 00093312901) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.